Related by context. All words. (Click for frequent words.) 72 unprotected vaginal 72 unprotected receptive anal 70 unprotected anal sex 70 receptive anal intercourse 69 serodiscordant 69 unprotected anal 69 insertive 68 serostatus 68 unprotected anal intercourse 67 serodiscordant couples 67 vaginal anal 66 discordant couples 66 uncircumcised males 66 non pledgers 66 penile vaginal intercourse 65 chlamydial infection 65 trichomonas 65 Circumcised men 64 anal intercourse 64 insertive partner 64 seroconverted 63 genital ulcers 63 genital ulcer 63 TDF FTC 63 urethritis 63 contracting STDs 63 Anal sex 63 perinatal transmission 63 HIV serostatus 63 anal HPV 63 HSV2 62 Sexually active 62 anal vaginal 62 serosorting 62 genital human papillomavirus 62 virginity pledgers 62 sexual intercourses 62 HIV seronegative 62 mutually monogamous 61 dyspareunia 61 genital ulcer disease 61 VivaGel TM 61 rectal gonorrhea 61 HIV uninfected 61 HBsAg positive 61 retrograde ejaculation 61 penetrative sex 61 oral herpes 61 vaginal intercourse 61 unprotected sexual intercourse 61 cervicitis 61 Trichomonas vaginalis 60 STIs sexually transmitted 60 genital lesions 60 se xual 60 Circumcision reduces 60 Chlamydia trachomatis infection 60 uncircumcised men 60 genital HPV infection 60 bacterial vaginosis BV 60 gonorrhea chlamydia 59 perinatally 59 Chlamydia gonorrhea 59 HIV seroconversion 59 cervical HPV 59 Opportunistic infections 59 anal warts 59 seronegative 59 bacterial vaginosis 59 penile anal 59 genital tract 59 orchitis 58 vaginal secretions 58 abnormal Pap smear 58 Genital herpes 58 syphilis gonorrhea chlamydia 58 Chlamydia infection 58 Genital HPV 58 valacyclovir 58 heterosexually 58 HPV subtypes 58 ovulatory cycles 58 vaginal lubrication 58 heterosexual intercourse 58 heterosexually acquired 58 Premature ejaculation 58 sexually active 58 gonococcal infections 58 coinfection 58 depot medroxyprogesterone acetate 57 FTC TDF 57 gonorrhea syphilis 57 genital secretions 57 Latex condoms 57 chlamydia trachomatis 57 ALISTA 57 seropositivity 57 C. trachomatis 57 inhibits ovulation 57 Schaffir 57 applied vaginally 57 cervical vaginal 57 male circumcision reduces 57 STDS 57 HIV seropositive 57 abnormal pap smears 57 heterosexual 57 NRTI backbone 57 Pneumocystis carinii pneumonia 57 virologic failure 57 acquire genital HPV 57 condom breakage 57 vulvar cancers 57 serologic testing 57 female genital tract 57 penile vaginal 57 irregular menstrual cycles 57 chlamydia herpes 56 clitoral orgasm 56 sexually transmitted HPV 56 urinary bowel 56 decompensated liver disease 56 INTRON therapy 56 dysfunctional voiding 56 maintain penile erection 56 Heavy menstrual bleeding 56 oral anal 56 attending antenatal clinics 56 antiretroviral naïve 56 Vaginal gel 56 NNRTI resistance 56 erection hardness 56 adolescent females 56 abnormal vaginal bleeding 56 abnormal Pap smears 56 spermicide nonoxynol 9 56 Human papillomavirus HPV 56 venereum 56 HepC 56 MSMs 56 PAP smears 56 external genital lesions 56 intercourse 56 vaginal penetration 56 untreated gonorrhea 56 HPV genotypes 56 Heterosexual transmission 56 T. vaginalis 56 chronic prostatitis 56 hepatitis C genotype 56 PAP smear 56 anal sex 56 hepatitis B infection 56 heterosexuality homosexuality 55 sexual intercourse 55 sero sorting 55 unprotected sex 55 sero positive 55 discontinued Viread 55 AZT 3TC 55 seropositive 55 Human papillomavirus 55 Sexually Transmitted Infections STI 55 vaginal irritation 55 herpes gonorrhea 55 sexually transmitted infection 55 pre exposure prophylaxis 55 syphilis gonorrhea 55 Pelvic Inflammatory Disease 55 pelvic inflammatory disease 55 undergone hysterectomies 55 anal cancers 55 ASCUS 55 preventing genital warts 55 vulvovaginal 55 abnormal Pap test 55 conjugated equine estrogen 55 secondary amenorrhea 55 Lipodystrophy 55 HBeAg negative 55 proctitis 55 hormone androgen 55 heterosexually acquired HIV 55 antibody titer 55 ano genital warts 55 virile reproductive 55 coinfected 55 chancroid 55 uninfected infants 55 HCV antibody 55 pneumocystis carinii pneumonia 55 axillary node 55 abnormal pap smear 55 dummy lookalike 55 hormones progesterone 55 spermicides 55 intravenous bisphosphonates 55 HBV HCV 55 chlamydia infections 55 blood semen vaginal 55 CCR5 tropic HIV 55 suppressive therapy 55 VivaGel ™ 55 colonoscopy sigmoidoscopy 55 herpes syphilis 55 lymphogranuloma venereum 55 Bacterial vaginosis 55 latent tuberculosis infection 55 genital herpes infections 55 hormone binding globulin 55 nonoxynol 9 55 antiretroviral naive 55 oncogenic HPV 55 tipranavir ritonavir 55 ALT flares 54 candidemia 54 varicella zoster virus VZV 54 Human Papilloma Virus 54 protease inhibitor PI 54 HPV-#/# 54 infant circumcision 54 UGT#A# * 54 psychiatric comorbidity 54 vaginismus 54 erectile dysfunction impotence 54 CIN3 54 Rakai Uganda 54 clade B 54 e antigen HBeAg 54 IELT 54 abdominal hysterectomy 54 herpes zoster virus 54 nulliparous women 54 anal lesions 54 diseases STDs 54 serum IgE 54 penile sensitivity 54 VivaGel ® 54 nonpregnant women 54 reproductive tract infections 54 Simian Immunodeficiency Virus 54 vaginal hysterectomy 54 genital herpes 54 tenofovir gel 54 nevirapine Viramune 54 penis vagina 54 anovulatory infertility 54 zidovudine AZT 54 genital HPV 54 intrauterine contraception 54 amenorrhoea 54 LYSTEDA 54 genital arousal 54 suppressing ovulation 54 endometrial thickness 54 co trimoxazole 54 antiandrogens 54 STDs 54 bladder bowel 54 HIV infection 54 Postmenopausal 54 N. gonorrhoeae 54 LNG IUS 54 virus HBV 54 placental malaria 54 lifetime abstainers 54 chlamydia sexually transmitted 54 potent antiretroviral therapy 54 IM progesterone 54 STI sexually transmitted 54 containing drospirenone 54 female endoscopist 54 vulvar vaginal 54 sexually transmitted infections 54 HPV Human Papillomavirus 54 superinfection 54 Peyronie Disease 54 elevated transaminases 54 Sustiva efavirenz 54 bacterial sexually transmitted 54 herpetic 53 virologically suppressed 53 anal penile 53 erectile difficulties 53 virus HCV 53 unprotected intercourse 53 C trachomatis 53 lipid elevations 53 empiric therapy 53 CMV infection 53 protease inhibitors PIs 53 iPrEx study 53 postexposure prophylaxis 53 gonorrhoeae 53 genital HPV infections 53 Nonoxynol 9 53 genital HSV 53 woman ovulates 53 perianal 53 vaginal infections 53 genotypic resistance 53 urinary leakage 53 investigational integrase inhibitor 53 fluoroquinolone resistance 53 NRTI resistance 53 gonorrhea Chlamydia 53 uterine perforation 53 Mantoux test 53 fibroids endometriosis 53 initiating antiretroviral therapy 53 gestational hypertension 53 TEAEs 53 Untreated chlamydia 53 ovulation induction 53 anorgasmia 53 virologically 53 follicular phase 53 homosexual intercourse 53 sexual transmitted infections 53 Vaginal dryness 53 R5 tropic 53 pentoxifylline 53 nonnucleoside reverse transcriptase inhibitors 53 trimethoprim sulfamethoxazole 53 LOVENOX R 53 pneumocystis pneumonia 53 circumcised males 53 lipohypertrophy 53 lupus anticoagulant 53 BRCA mutation 53 Chlamydia trachomatis 53 endometrial biopsy 53 morphometric vertebral fractures 53 NRTI 53 subfertility 53 hepatitis C HCV 53 BCG vaccinated 53 gonorrhea chlamydia syphilis 53 lichen planus 53 Sexual intercourse 53 HIV 53 del 5q MDS 53 gonorrhea 53 CIN3 + 53 HIV coinfected 53 bisexual 53 syphilis chlamydia 53 human papilloma 53 quinolone resistant 53 stimulate ovulation 53 P. falciparum malaria 53 premenstrual syndrome PMS 53 Viread Emtriva 53 vaginal cancers 53 immunosuppressed patients 53 transsexuals transvestites 53 Ectopic pregnancy 53 monogamous relationships 53 nelfinavir 53 APTIVUS ritonavir 53 inner foreskin 53 vulvar pain 53 HBsAg 53 PREZISTA ritonavir 53 quadrivalent vaccine 53 BRCA2 mutations 53 HIV coinfection 53 REYATAZ ® 53 receiving antiretroviral therapy 53 GARDASIL ® 53 BRCA mutation carriers 53 transaminase elevations 53 seroconversion 53 % CI #.#-#.# [003] 53 ethambutol 53 prophylactic mastectomies 53 sexually transmissible 53 rhGH 53 breast tenderness 53 anagrelide 53 tuberculosis hepatitis B 53 ritonavir boosted protease inhibitor 53 pelvic examinations 53 sometimes symptomless infection 53 APOE genotype 53 Recombinant interferon alpha 53 recurrent glioblastoma multiforme 53 PREZISTA r 53 Pap smear screening 53 PrEP 53 chlamydia gonorrhea syphilis 53 FSWs 53 acquired immunodeficiency syndrome 53 oesophageal adenocarcinoma 52 Human immunodeficiency virus 52 HIV1 52 hepatitis B immunoglobulin 52 trivalent inactivated influenza 52 ENDOMETRIN 52 hormone estradiol 52 perinatally infected 52 hMG 52 bilateral oophorectomy 52 ddI 52 ejaculatory dysfunction 52 Candida species 52 mIU ml 52 chlamydia infection 52 genitally 52 oestradiol 52 SHBG levels 52 Sexually Transmitted Infections STIs 52 azoospermia 52 sexual transmitted diseases 52 HBV genotype 52 flutamide 52 testicular tumors 52 Dr. Maria Wawer 52 penetrative intercourse 52 chlamydial infections 52 anti HBs 52 aciclovir 52 Rh factor 52 anogenital 52 Male infertility 52 treatment naïve genotype 52 antiandrogen 52 SLNB 52 heterosexuals 52 tuberculin skin testing 52 norgestimate 52 varicella infection 52 gametocytes 52 fetal chromosomal 52 Gag polymorphisms 52 herpes zoster vaccine 52 APTIVUS r 52 NNRTI 52 Combination antiretroviral therapy 52 nucleotide analogue 52 HPV infects 52 precancerous cervical 52 finasteride Proscar 52 HPV# 52 syphilis infections 52 elevated ALT 52 varicoceles 52 CCR5 tropic 52 microbicide gels 52 undetectable viral loads 52 ESBL producing E. coli 52 recurrent VTE 52 habitual snoring 52 homosexually active 52 Sexually transmitted infections 52 Multicenter AIDS 52 FC2 female 52 STIs 52 triple nucleoside regimen 52 severe rotavirus gastroenteritis 52 ® emtricitabine 52 HCV replicon 52 hepatitis syphilis 52 experimental therapeutics Ampligen 52 System IPSS 52 indinavir 52 H Pylori 52 Viread tenofovir disoproxil fumarate 52 hormone hCG 52 infertility ectopic pregnancy 52 carbohydrate intolerance 52 trastuzumab Herceptin ® 52 antenatal depression 52 transmitted heterosexually 52 Klinefelter syndrome 52 chemoprophylaxis 52 atypical ductal hyperplasia 52 Anal cancer 52 Protease Inhibitors 52 parous women 52 wart virus 52 Chlamydia pneumoniae 52 luteal 52 atypical hyperplasia 52 Zestra TM 52 P aeruginosa 52 multivariate analyzes 52 sexually transmitted 52 invasive carcinoma 52 vagina anus 52 asymptomatic carriers 52 penile penetration 52 clomiphene citrate 52 oral PrEP 52 menopause contraception 52 ABC/3TC 52 nonpregnant 52 cervical lesions 52 lymphogranuloma venereum LGV 52 uterus fallopian tubes 52 Herpes Simplex Virus 52 liver transplant recipients 52 poliovirus vaccine 52 cervix vagina 52 dysuria 52 TB germ 52 monoinfected patients 52 psychiatric comorbidities 52 analgesic medications 52 CP CPPS 52 contracting sexually transmitted 52 Hypoactive Sexual Desire Disorder 52 reactogenicity 52 BRCA1 mutation carriers 52 relapsed MM 52 advanced adenoma 52 organ prolapse 52 HIV seroprevalence 51 GnRH antagonist 51 viremic 51 vaginitis 51 abdominal ultrasounds 51 men lesbians bisexuals 51 Mg Uk 51 chronic HBV 51 intravaginal ejaculatory latency 51 genitourinary medicine 51 HCV genotype 51 varicocele 51 genotype 1b 51 combination antiretroviral therapy 51 NNRTI resistant virus 51 intravaginal 51 cotrimoxazole prophylaxis 51 undetectable HBV DNA 51 tenofovir emtricitabine 51 loop diuretic 51 penis scrotum 51 HBV infection 51 aged ≥ 51 Dr. Premlata Chawla 51 virologic responses 51 topical microbicides 51 abstinence faithfulness 51 gonococcal 51 VivaGel 51 HCV genotypes 51 subfertile 51 postoperative infections 51 Human papilloma virus 51 HCV antibodies 51 abnormal cytology 51 Lysteda 51 vaginal estrogen 51 serum lipid levels 51 baseline CD4 51 Follicle Stimulating Hormone FSH 51 Genital Herpes 51 nonvaccine 51 abnormal Pap 51 vaginal lesions 51 endometrial carcinoma 51 abacavir lamivudine 51 Pubic lice 51 Bacille Calmette Guerin BCG 51 IgM antibodies 51 abacavir Ziagen 51 anogenital distance 51 thromboembolic disease 51 cART 51 log# reduction 51 cervical vulvar 51 GH deficiency 51 REYATAZ r arm 51 oral contraceptive pills 51 Neisseria gonorrhoeae 51 HSV1 51 prevalences 51 Heterosexual 51 seropositive patients 51 testicular germ cell 51 sexually transmitted diseases 51 endometrial hyperplasia 51 immunocompetent 51 HIVMA promotes quality 51 vulvar cancer 51 unprotected heterosexual intercourse 51 Havrix 51 involuntary deviant 51 painful menstrual periods 51 vaginal fluids 51 intercourses 51 causes genital herpes 51 unwanted pregnancies sexually transmitted 51 Cohort Study MACS 51 herpes simplex virus 51 pelvic lymphadenectomy 51 hormone receptor negative 51 mycophenolate mofetil MMF 51 oropharyngeal cancers 51 BRAF V#E mutation 51 transfusion transmitted 51 enfuvirtide 51 HCV genotype 1 51 gonorrhea infections 51 Antiretroviral therapy 51 Syndrome HARS 51 Unprotected sex 51 unexplained infertility 51 solifenacin 51 thyrotropin levels 51 H pylori 51 cervix vulva 51 sexually transmitted infections STIs 51 CIN2 + 51 irregular menses 51 transmitted infections 51 Hepatitis B Virus 51 P falciparum 51 Infected Patients 51 hormonal contraception 51 penetrative sexual 51 chronic HCV genotype 51 heterosexual males 51 tumor histology 51 anus rectum 51 3TC lamivudine Epivir 51 Carraguard 51 spermicidal 51 bacterium Chlamydia trachomatis 51 norethindrone 51 precancerous condition 51 HBV infections 51 zidovudine lamivudine 51 Progestin 51 Genital warts 51 radical retropubic prostatectomy 51 onset idiopathic hypogonadism 51 tuberculin skin test 51 users IDUs 51 clodronate 51 phimosis 51 oropharyngeal cancer 51 chlamydial 51 tenofovir FTC 51 homosexually 51 squamous intraepithelial lesions 51 TMP SMX 51 undetectable viral load 51 PIGF 51 gonadal 51 Depo Provera injections 51 recurrent venous thromboembolism 51 induce ovulation 51 urinary symptoms 51 suboptimal adherence 51 endometrial biopsies 51 Tenofovir gel 51 fluconazole resistant 51 penile vaginal penetration 51 HIVAN 51 PREZISTA rtv 51 SE alleles 51 human immuno deficiency 51 topical microbicide 51 Human Papillomavirus 51 coinfected patients 51 Naive Patients 51 ritonavir boosted lopinavir 51 d4T stavudine Zerit 51 antiviral therapy 51 Chastity Bono announces 51 lipoatrophy 51 uncircumcised penis 51 vesicoureteral reflux 51 Human Virus HPV 51 AOR = 51 deafness neurological 50 nonexposed 50 condom 50 impaired insulin secretion 50 preeclamptic 50 hemorrhagic cystitis 50 grade squamous intraepithelial 50 pre eclamptic 50 IGRAs 50 HMPV 50 genitourinary tract 50 GnRH agonists 50 serologically 50 adverse reactions incidence 50 latent TB infection 50 sexual arousal disorder 50 HBeAg 50 prolonged QT interval 50 vaginal atrophy 50 rectal microbicides 50 rectal swab 50 leiomyomas 50 initiating HAART 50 preventive mastectomies 50 Abacavir 50 Hepatitis B HBV 50 G6PD deficiency 50 lopinavir ritonavir Kaletra 50 tolterodine ER 50 Gilead Viread 50 menstrual abnormalities 50 polysaccharide vaccines 50 hypogonadal 50 AndroGel ® 50 malaria endemic regions 50 glucocorticoid induced osteoporosis 50 Kivexa 50 MRSA colonization 50 gestational diabetes mellitus 50 antimuscarinic 50 Uncircumcised 50 recurrent UTI 50 darunavir r 50 asymptomatic bacteriuria 50 S. aureus isolates 50 syphilis herpes 50 peri natal 50 thrombocytopenic 50 penile cancers 50 glans penis 50 locoregional recurrence 50 hiv 50 CCR5 delta# 50 K#N 50 vagina cervix 50 #q# deletion 50 HAART regimen 50 faecal incontinence 50 ovulation inducing 50 shingles vaccine Zostavax 50 Ovarian cysts 50 ertapenem 50 RhD 50 clomipramine 50 ziconotide 50 recurrent genital herpes 50 clitoral stimulation 50 epididymitis 50 HIV sero 50 herpes zoster shingles 50 estradiol valerate 50 zidovudine 50 APOE ε4 50 gestational diabetes mellitus GDM 50 LTBI 50 beta estradiol 50 Enlarged prostate 50 Male circumcision 50 BRCA1 mutation 50 HPV prevalence 50 NAbs 50 undergone hysterectomy 50 plus medroxyprogesterone acetate 50 β blocker 50 MiraCare TM Rapid 50 perianal warts 50 apolipoprotein E4 50 bacterium Treponema pallidum 50 virological response 50 anal incontinence 50 GUM clinics 50 vaginal odor 50 Protease inhibitor 50 HBV DNA 50 VIRAMUNE XR 50 sexually transmitted disease 50 SCIg 50 IPTp 50 prostate TURP 50 efavirenz EFV 50 oral thrush 50 HBeAg positive patients 50 cytomegalovirus infection 50 estrogen deficiency 50 ART regimens 50 coinfections 50 corticosterone levels 50 AVODART 50 estim ated fewer 50 chlamydia genital herpes 50 H.I.V. 50 Plasmodium ovale 50 circumcised penis 50 Hormonal therapy 50 topical testosterone 50 acyclovir valacyclovir 50 polytherapy 50 teratogenic 50 HBeAg positive 50 anthrax botulism typhoid 50 Hormonal contraceptives 50 Nutritional Supplementation 50 prostate cancer CaP 50 danazol 50 fluoroquinolone resistant 50 HPVs 50 thromboembolism 50 suppress ovulation 50 Rhesus disease 50 BRCA2 gene mutation 50 USA# strain 50 heritable variation 50 AZT zidovudine Retrovir 50 Candida infection 50 SPM Rated PG 50 Uterine cancer 50 colorectal adenoma 50 Bacterial Vaginosis 50 PRO# [002] 50 consenting adult 50 nonforcible 50 Amniocentesis 50 spontaneous preterm birth 50 hypogonadotropic hypogonadism 50 gynecological examinations 50 C. pneumoniae 50 SGPT 50 tamoxifen Nolvadex ® 50 perioperative complications 50 CCR5 inhibitor 50 % CI #.#-#.# [006] 50 recurrent miscarriage 50 androgen hormone 50 metronidazole gel 50 chronic HBV infection 50 isoniazid preventive therapy 50 enteric fever 50 LC#m# vaccine 50 Adjuvant chemotherapy 50 Widths vary 50 synthetic progesterone 50 pharmacokinetic interactions 50 Herpes simplex virus 50 conjugated estrogen 50 Virologic failure 50 androgen deficiency 50 HCV infected 50 etiologic agent 50 sulfamethoxazole 50 shorter telomere length 50 pelvic prolapse 50 Zestra R 50 pyrimethamine 50 latent celiac disease 50 hepatitis viruses 50 M. genitalium 50 acromegalic patients 50 CCR5 antagonist 50 HEPLISAV combines 50 perimenopausal women 50 hematological parameters 50 sexual disfunction 50 ritonavir boosted atazanavir 50 precancers 50 venous blood clots 50 perioperatively 50 female genital 50 Gardasil vaccine protects 50 CC genotype 50 papilloma 50 condom usage 50 androgen deprivation 50 Herpes Zoster 50 clinically asymptomatic 50 Celsentri Selzentry 50 cervical intraepithelial neoplasia 50 medroxyprogesterone acetate 50 â ‰ ¥ 50 Preterm delivery 50 virologic response 50 abstinence monogamy 50 WNV infections 50 nonadherent 50 Aortic stenosis 50 monoinfected 50 Effexor venlafaxine 50 proguanil 50 nevirapine regimen 50 carotid plaques 50 hip BMD 50 therapists swingers 50 ketoconazole 50 intrapartum 50 papilloma viruses 50 MGUS 50 pulmonary TB 50 d4T 50 infections STIs 50 anal penetration 50 uninfected 50 Ad5 immunity 50 Wistar rats 50 decreased libido 50 insomnia sufferers 50 Human Papillomavirus Quadrivalent Types 50 TRIAD HELP GROUP 50 polycystic ovary syndrome PCOS 50 slow progressors 50 intersexuality 49 CMV retinitis 49 CYP#D# gene 49 gonococcal infection 49 bowel bladder 49 neomycin 49 HPV infection 49 contaminated needles 49 Unplanned pregnancies 49 premature ejaculation PE 49 multivariate logistic regression 49 neonatal circumcision 49 vaginal tract 49 T1DM 49 hypophosphatemia 49 causes genital warts 49 obstetric complications 49 Gag Pol 49 delaying ovulation 49 Ejaculation 49 fructose intolerance 49 Subgroup analyzes 49 Ushercell 49 Catheter Associated 49 Kaposi sarcoma 49 CD4 + cell 49 cotrimoxazole 49 Simian Immunodeficiency Virus SIV 49 VIR# 49 spontaneous preterm delivery 49 inactivated poliovirus 49 HIV HCV coinfected 49 Chlamydia infections 49 bloodborne 49 CYP#D# inhibitor 49 Valtrex valacyclovir 49 Chlamydia Gonorrhea 49 deep venous thromboses 49 efavirenz Sustiva 49 HAV infection 49 pelvic girdle pain 49 precancerous cervical lesions 49 accomplice Hudgens 49 familial clustering 49 Polycystic ovary syndrome PCOS 49 drospirenone containing 49 FORTESTA Gel 49 dormant chickenpox 49 inhibit ovulation 49 untreated chlamydia 49 hormone therapy estrogen 49 drank decaffeinated coffee 49 Heterozygous Familial Hypercholesterolemia 49 HBeAg seroconversion 49 dose intramuscular 49 xual 49 Mustanski 49 reinfection 49 HPV Infection 49 venous thromboembolic events 49 Urinary tract infections UTIs 49 obstructive coronary artery 49 uncircumcised counterparts 49 IgA deficiency 49 TT genotype 49 Vaginal rings 49 oral poliovirus 49 entecavir 49 histologic subtype 49 spontaneous miscarriages 49 Acquired Immunodeficiency Syndrome 49 loop diuretics 49 MenACWY 49 postnatally 49 SRY gene 49 AZT zidovudine 49 gynecological examination 49 virological failure 49 Levonorgestrel 49 ibandronate 49 albumin excretion 49 irregular menstrual cycle 49 MiraWell TM Rapid 49 co trimoxazole prophylaxis 49 cytopathic 49 relapsed ALL 49 anovulation 49 ABCB1 49 HPV infections 49 hematologic abnormalities 49 vitamin D inadequacy 49 dysplastic lesions caused 49 intractable hiccups 49 TA NIC